Exousia Bio (LMMY) Income from Continuing Operations (2022 - 2025)
Lamy (LMMY) has disclosed Income from Continuing Operations for 4 consecutive years, with 19083.0 as the latest value for Q4 2025.
- Quarterly Income from Continuing Operations fell 123.82% to 19083.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 7486.0 through Nov 2025, down 88.68% year-over-year, with the annual reading at 51395.0 for FY2025, 299.15% up from the prior year.
- Income from Continuing Operations hit 19083.0 in Q4 2025 for Lamy, up from 31814.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 80129.0 in Q4 2024 to a low of 31814.0 in Q3 2025.
- Historically, Income from Continuing Operations has averaged 105.43 across 4 years, with a median of 6761.0 in 2023.
- Biggest five-year swings in Income from Continuing Operations: skyrocketed 2342.63% in 2024 and later plummeted 713.45% in 2025.
- Year by year, Income from Continuing Operations stood at 8407.0 in 2022, then soared by 57.5% to 3573.0 in 2023, then surged by 2342.63% to 80129.0 in 2024, then tumbled by 123.82% to 19083.0 in 2025.
- Business Quant data shows Income from Continuing Operations for LMMY at 19083.0 in Q4 2025, 31814.0 in Q3 2025, and 3500.0 in Q2 2025.